People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Other Technology, Pharma, Healthtech, Software / Tech, Computers, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neo4j, Inc. | — | Other Technology | Series D+ | $272.1M | $4.2B | 2018 |
| Cogito Corp | — | Other Technology | Series C | $159.1M | $865.6M | 2014 |
| Click Therapeutics, Inc. | — | Pharma | Series C | $136.7M | $332.0M | 2014 |
| Transparent Health Marketplace, Inc. | — | Healthtech | Series B | $57.8M | $53.9M | 2019 |
| Avalon Health Services, LLC | — | Healthtech | Series B | $45.8M | $408.9M | 2016 |
| NextHealth Technologies, Inc. | — | Software / Tech | Series B | $30.3M | $60.0M | 2018 |
| Document Security Systems Inc | — | Other Technology | Seed | $8.9M | $93.7M | 2012 |
| DHK Storage, LLC | — | Computers | Seed | $2.6M | $106.1M | 2017 |
| DCP Partners LLC | — | Other | Pre-Seed | $300K | $2.0M | 2023 |
| Dmb Pest Llc | — | Other | Pre-Seed | $191K | $771K | 2024 |
David Klein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Klein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Maxwell | 1 | 11 |
| LEE SHAPIRO | 1 | 10 |
| Casper De Clercq | 1 | 9 |
| Krishna Gupta | 1 | 9 |
| Adam Boehler | 1 | 8 |
| John Cronin | 1 | 8 |
| Stuart Peterson | 1 | 7 |
| Alon Krashinsky | 1 | 6 |
| Robert Coppedge | 1 | 6 |
| Uri Geiger | 1 | 6 |
| Philip Jones | 1 | 5 |
| William Kerr | 1 | 3 |
| Ira Greenstein | 1 | 3 |
| Patrick White | 1 | 3 |
| Muzammil Mansuri | 1 | 3 |
| Patrick Pichette | 1 | 3 |
| Michael Treskow | 1 | 3 |
| Alex Zisson | 1 | 3 |
| Steven Morgan | 1 | 3 |
| Jeffrey Berkowitz | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.